Tian Liu, PhD
Cancer Researcher

The use of advanced imaging technologies in radiotherapy will allow us to better evaluate and manage treatment-related side effects, ultimately improving quality of life for cancer survivors.

Winship Cancer Institute Executive Director Walter J. Curran, Jr., MD and cancer researcher Tian Liu, PhD conducted clinical and translational trials to develop multi-modality imaging technologies to evaluate tumor and normal-tissue responses following radiotherapy treatment.

Dr. Liu's research group has pioneered the use of ultrasound imaging in monitoring and predicting normal-tissue toxicity in cancer radiotherapy. Through this work, radiation oncologists will be able to better quantify radiation-induced side effects and will be able to improve the quality of life of cancer survivors. 

Learn more about clinical trials at Winship Cancer Institute.

 


Photo of Tian Liu, PhD
Cascade Link   TOP